Mark A. Miller
12Patents
4h-index
24Co-inventors
60Inventor score
Filing activity: Aug 12, 1991 → Jul 8, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7648962B2 | Natriuretic compounds, conjugates, and uses thereof | Human Necessities | 33 | Expired |
| US7662773B2 | Natriuretic compounds, conjugates, and uses thereof | Chemistry; Metallurgy | 27 | Active |
| US7605123B2 | Fatty acid formulations for oral delivery of proteins and peptides, and uses thereof | Human Necessities | 18 | Active |
| US7875700B2 | Cation complexes of insulin compound conjugates, formulation and uses thereof | Human Necessities | 7 | Active |
| US7872095B2 | Insulin-oligomer conjugates, formulations and uses thereof | Human Necessities | 4 | Active |
| US7718182B2 | Polypeptides for inducing a protective immune response against Staphylococcus aureus | Human Necessities | 0 | Expired |
| US8747858B2 | Staphylococcus aureus surface protein SA1789 and protective vaccine based thereon | Human Necessities | 0 | Active |
| US9101596B2 | Cation complexes of insulin compound conjugates, formulations and uses thereof | Human Necessities | 0 | Active |
| US8658180B2 | Vaccines against influenza virus | Chemistry; Metallurgy | 0 | Active |
| US9102758B2 | Insulin-oligomer conjugates, formulations and uses thereof | Human Necessities | 0 | Active |
| US8563685B2 | Fatty acid formulations and oral delivery of proteins and peptides, and uses thereof | Human Necessities | 0 | Active |
| US5397696A | Papua New Guinea human T-lymphotropic virus | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.